Cargando…
Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
Low grade gliomas (LGGs) of pineal region are usually difficult to remove and they frequently relapse or progress after front line chemotherapy. Bevacizumab-Irinotecan (BEVIRI) combination has been successfully attempted in children with recurrent LGGs, in most cases not previously irradiated. The e...
Autores principales: | Castelli, Barbara, Fonte, Carla, Guidi, Milena, Tellini, Marco, Di Nicola, Marco, Iacono, Alessandro, Buccoliero, Anna Maria, Greto, Daniela, Genitori, Lorenzo, Sardi, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547897/ https://www.ncbi.nlm.nih.gov/pubmed/37799478 http://dx.doi.org/10.3389/fonc.2023.1244628 |
Ejemplares similares
-
Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
por: Buccoliero, Anna Maria, et al.
Publicado: (2022) -
Use of High-Dose Chemotherapy in Front-Line Therapy of Infants Aged Less Than 12 Months Treated for Aggressive Brain Tumors
por: Guidi, Milena, et al.
Publicado: (2020) -
Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas
por: Masselli, Marika, et al.
Publicado: (2012) -
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
por: Mesti, Tanja, et al.
Publicado: (2015) -
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
por: Detti, Beatrice, et al.
Publicado: (2021)